Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway Lipid Signaling PLA

Anti-LPLA2 antibody (ab154012)

Anti-LPLA2 antibody (ab154012)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to LPLA2
  • Suitable for: WB, IHC-P
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Recombinant Human PLA2G12B protein (ab135016)
Product image
Anti-LPLA2 antibody (ab111898)
Quinacrine dihydrochloride, Non-selective phospholipase A2 inhibitor (ab120749)
Product image
Human PLA2G15 (LPLA2) knockout HeLa cell line (ab265293)

Overview

  • Product name

    Anti-LPLA2 antibody
    See all LPLA2 primary antibodies
  • Description

    Rabbit polyclonal to LPLA2
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    IHC-P
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Recombinant fragment corresponding to Human LPLA2 aa 224-412.
    Database link: Q8NCC3

  • Positive control

    • HepG2 cell lysate, Human colon carcinoma tissue.
  • General notes

    Store as concentrated solution.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • Storage buffer

    pH: 7.00
    Preservative: 0.01% Thimerosal (merthiolate)
    Constituents: 78.99% PBS, 1% BSA, 20% Glycerol (glycerin, glycerine)
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Signaling Pathway
    • Lipid Signaling
    • PLA
    • Epigenetics and Nuclear Signaling
    • Nuclear Signaling Pathways
    • Nuclear Receptors
    • Retinoic & Retinoid
    • Signal Transduction
    • Metabolism
    • Lipid metabolism

Images

  • Western blot - Anti-LPLA2 antibody (ab154012)
    Western blot - Anti-LPLA2 antibody (ab154012)
    Anti-LPLA2 antibody (ab154012) at 1/1000 dilution + HepG2 whole cell lysate at 30 µg

    Predicted band size: 47 kDa



    10% SDS PAGE
  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LPLA2 antibody (ab154012)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LPLA2 antibody (ab154012)

    Immunohistochemical analysis of paraffin-embedded Human colon carcinoma tissue, labeling LPLA2 with ab154012 at 1/500 dilution.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-LPLA2 antibody (ab154012)

  •  
  • Product image

    Anti-LPLA2 antibody (ab111898)

    Applications: ICC/IF, IHC-P, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-NUP214 antibody (ab70497)

  •  
  • Product image

    Anti-KCC1 antibody (ab115607)

  •  
  • Product image

    Anti-PTHLH antibody (ab224503)

  •  
  • Product image

    Anti-BRIP1 antibody (ab126517)

  •  
  • Product image

    Anti-Secretogranin V antibody (ab224090)

  •  
  • Product image

    Anti-p63 antibody (ab114059)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.